Peter Wirth is of Zai Lab Ltd. Currently has a direct ownership of 382,919 shares of ZLAB, which is worth approximately $10.2 Million. The most recent transaction as insider was on Jun 18, 2024, when has been sold 21,253 shares (American Depositary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 383K
0% 3M change
5.88% 12M change
Total Value Held $10.2 Million

PETER WIRTH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2024
BUY
Grant, award, or other acquisition
-
21,253 Added 5.26%
382,919 American Depositary Sh...
Jun 29 2023
BUY
Grant, award, or other acquisition
$499,984 $26.45 p/Share
18,903 Added 4.97%
361,666 American Depositary Sh...
Dec 08 2022
SELL
Open market or private sale
$136,245 $35.37 p/Share
3,852 Reduced 1.11%
342,763 American Depositary Sh...
Jan 03 2022
BUY
Grant, award, or other acquisition
-
7,763 Added 2.17%
350,615 Ordinary Shares
Dec 08 2021
BUY
Open market or private purchase
$285,440 $71.36 p/Share
4,000 Added 1.15%
342,852 Ordinary Shares
Jan 15 2021
BUY
Grant, award, or other acquisition
-
3,852 Added 1.12%
338,852 Ordinary Shares

Also insider at

SYRS
Syros Pharmaceuticals, Inc. Healthcare
FMTX
Forma Therapeutics Holdings, Inc. Healthcare
PW

Peter Wirth

Cambridge, MA

Track Institutional and Insider Activities on ZLAB

Follow Zai Lab Ltd and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZLAB shares.

Notify only if

Insider Trading

Get notified when an Zai Lab LTD insider buys or sells ZLAB shares.

Notify only if

News

Receive news related to Zai Lab Ltd

Track Activities on ZLAB